Vyne Therapeutics Share Price (NASDAQ: VYNE)
$0.33
Live
Last updated on
Check the interactive Vyne Therapeutics Stock chart to analyse performance
Vyne Therapeutics stock performance
as on August 26, 2025 at 12:40 AM IST
- Today's Low:$0.33Today's High:$0.33
0.0%
Downside
Day's Volatility :0.99%
Upside
0.99%
- 52 Weeks Low:$0.3252 Weeks High:$4.30
3.76%
Downside
52 Weeks Volatility :92.61%
Upside
92.33%
Vyne Therapeutics Stock Returns
Vyne Therapeutics Inc Key Stats
Check Vyne Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Vyne Therapeutics Stock including INR - Dollar returns
The Vyne Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vyne Therapeutics investment value today
Current value as on today
₹22,173
Returns
Returns from Vyne Therapeutics Stock
Dollar Returns*
₹4,335 (+4.33%)
Indian investors sentiment towards Vyne Therapeutics Stock
Global Institutional Holdings in Vyne Therapeutics Inc
Name
Holdings %
Eventide Asset Management, LLC
7.05%
Cormorant Asset Management, LLC
6.93%
Citadel Advisors Llc
5.56%
Dafna Capital Management LLC
3.22%
Kennedy Capital Management Inc
2.89%
Vanguard Group Inc
2.51%
Analyst Recommendation on Vyne Therapeutics Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Vyne Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Vyne Therapeutics Share Price Target
What analysts predicted
Upside of 1112.12%
Target:
$4.00
Current:
$0.33
Vyne Therapeutics share price target is $4.00, a slight Upside of 1112.12% compared to current price of $0.33 as per analysts' prediction.
Vyne Therapeutics Stock Insights
Price Movement
In the last 1 month, VYNE stock has moved down by -77.1%Decreasing Revenue
Revenue is down for the last 2 quarters, 202.0K → 69.0K (in $), with an average decrease of 65.8% per quarterIncreasing Net Profit
Netprofit is up for the last 4 quarters, -12.15M → -5.75M (in $), with an average increase of 30.1% per quarterVYNE vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.7% return, outperforming this stock by 148.8%VYNE vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.4% return, outperforming this stock by 206.7%Price to Sales
ForVYNE every $1 of sales, investors are willing to pay $30.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.
Vyne Therapeutics Inc Financials
Vyne Therapeutics Technicals Summary
Sell
Neutral
Buy
Vyne Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Vyne Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -76.97% | -88.07% | -81.95% | -94.28% | -99.68% |
 | 5.52% | -17.35% | -50.85% | -1.12% | -3.68% |
 | 6.51% | 21.35% | 57.45% | 73.21% | 25.84% |
 | -14.26% | -17.97% | -18.13% | 40.27% | 45.64% |
 | 39.9% | 82.53% | 68.83% | 115.41% | 241.51% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 1.74 | NA | NA | -0.89 | -0.68 | -0.41 | NA | 1.97 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 28.08 | 28.08 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $6.6M | -99.68% | 1.74 | 0.0% |
| Buy | $62.5B | -3.68% | 14.86 | 31.37% |
| NA | $38.3B | 25.84% | NA | -3.89% |
| Buy | $101.3B | 45.64% | 28.08 | 31.86% |
| Buy | $59.6B | 241.51% | NA | -12.96% |
About Vyne Therapeutics Inc
Key Management of Vyne Therapeutics Inc
Important FAQs about investing in VYNE Stock from India :
What is Vyne Therapeutics share price today?
Vyne Therapeutics share price today is $0.33 as on . Vyne Therapeutics share today touched a day high of $0.33 and a low of $0.33.
What is the 52 week high and 52 week low for Vyne Therapeutics share?
Vyne Therapeutics share touched a 52 week high of $4.30 and a 52 week low of $0.32. Vyne Therapeutics stock price today i.e. is trending at $0.33, lower by 92.33% versus the 52 week high.
How to invest in Vyne Therapeutics Stock (VYNE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Vyne Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vyne Therapeutics Shares that will get you 4.5455 shares as per Vyne Therapeutics share price of $0.33 per share as on August 26, 2025 at 12:40 AM IST.
What is the minimum amount required to buy Vyne Therapeutics Stock (VYNE) from India?
Indian investors can start investing in Vyne Therapeutics (VYNE) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Vyne Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 25, 2025).
Based on Vyne Therapeutics share’s latest price of $0.33 as on August 26, 2025 at 12:40 AM IST, you will get 30.3030 shares of Vyne Therapeutics. Learn more about
fractional shares .
What are the returns that Vyne Therapeutics has given to Indian investors in the last 5 years?
Vyne Therapeutics stock has given -99.68% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Global X S&p 500 Tail Risk Etf
$29.08
-0.27%
- Rareview Total Return Bond Etf
$24.99
-0.24%
S&p Pharmaceuticals Spdr Etf$47.11
-0.44%
- Cambria Value And Momentum Etf
$32.05
-0.31%
- Invesco Bs 2033 Hycb Etf
$25.36
+0.0%
Ishares Msci Peru And Global Exposure Etf$53.44
+0.39%
- Ishares Intl Div Growth Etf
$79.45
-0.54%
- Lg Qraft Ai-powered Us Large Cap Core Etf
$37.81
-0.45%
- Above Food Ingredients Inc Wt Exp 062829
$0.20
+5.26%